Trial Profile
The impact of Hepatitis C viral load determined short-course treatment vs fixed duration treatment on Hepatitis C cure for patients with mild genotype-1 Hepatitis C disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2021
Price :
$35
*
At a glance
- Drugs Ombitasvir/paritaprevir/ritonavir (Primary) ; Dasabuvir; Glecaprevir/pibrentasvir; Ledipasvir/sofosbuvir; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms STOPHCV-1
- 02 Nov 2019 Status changed from active, no longer recruiting to completed.
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Apr 2016 New trial record